From the Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Landmark Center, Boston, MA.
Menopause. 2022 Sep 1;29(9):1021-1027. doi: 10.1097/GME.0000000000002014. Epub 2022 Aug 2.
The aim of this study was to evaluate the associations of a lifetime history of hypertensive disorders of pregnancy (HDP) and gestational diabetes mellitus (GDM) with menopausal symptoms in midlife.
This was a secondary analysis of women participating in Project Viva, an ongoing cohort enrolled during pregnancy. The exposure was lifetime history of HDP or GDM assessed for the index pregnancy by review of outpatient and hospital medical records and for all other pregnancies by interview or questionnaire at study entry (1999-2002) and the midlife visit (2017-2021). The primary outcome was the Menopause Rating Scale (MRS) applied at the midlife study visit. We used linear or logistic regression models adjusted for covariates such as baseline age, race/ethnicity, education, married/cohabiting, household income, baseline parity, age at menarche, and body mass index at midlife.
Of the 676 included participants, 120 (18%) had a history of HDP, and 47 (7%) had a history of GDM. The mean (SD) age was 52 (3.9) years at the midlife visit, and 48% of the participants had experienced menopause. There were no consistent differences in total, domain-specific, or individual symptoms in women with a history of HDP or GDM. A history of HDP and/or GDM was not associated with age at the onset of natural menopause.
Our findings do not support an association of a history of HDP or GDM with the severity of menopausal symptoms or age at the onset of natural menopause. Larger studies of women with a history of these pregnancy complications are needed to clarify their association with menopausal symptoms.
本研究旨在评估妊娠高血压疾病(HDP)和妊娠期糖尿病(GDM)的终生病史与中年绝经症状的相关性。
这是对参加 Viva 项目的女性进行的二次分析,该项目是在妊娠期间招募的一个正在进行的队列。通过回顾门诊和医院病历评估索引妊娠时的 HDP 或 GDM 病史,通过研究入组时(1999-2002 年)和中年访问时(2017-2021 年)的访谈或问卷评估所有其他妊娠时的 HDP 或 GDM 病史。主要结局是在中年研究访问时应用绝经评定量表(MRS)。我们使用线性或逻辑回归模型,根据基线年龄、种族/民族、教育程度、已婚/同居、家庭收入、基线产次、初潮年龄和中年时的体重指数等协变量进行调整。
在纳入的 676 名参与者中,120 名(18%)有 HDP 病史,47 名(7%)有 GDM 病史。在中年访问时,平均(SD)年龄为 52(3.9)岁,48%的参与者已经绝经。有 HDP 或 GDM 病史的女性在总症状、特定领域症状或个别症状方面没有一致的差异。HDP 和/或 GDM 病史与自然绝经的起始年龄无关。
我们的研究结果不支持 HDP 或 GDM 病史与绝经症状严重程度或自然绝经起始年龄之间存在关联。需要对有这些妊娠并发症史的女性进行更大规模的研究,以阐明它们与绝经症状的关联。